These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 37964957

  • 21. Maternal pre-pregnancy BMI, MTHFR polymorphisms, and the risk of adverse pregnancy outcomes in pregnant women from South China: a retrospective cohort study.
    Gu C, Wu W, Lai K, Li H, Wu L, Lu W, Ruan X, Luo M.
    BMC Pregnancy Childbirth; 2023 Apr 27; 23(1):295. PubMed ID: 37106323
    [Abstract] [Full Text] [Related]

  • 22. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
    Xiong Y, Bian C, Lin X, Wang X, Xu K, Zhao X.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32639550
    [Abstract] [Full Text] [Related]

  • 23. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
    Bai R, Liu W, Zhao A, Zhao Z, Jiang D.
    Mol Biol Rep; 2013 Mar 31; 40(3):2419-30. PubMed ID: 23229495
    [Abstract] [Full Text] [Related]

  • 24. Association of MTHFR gene C677T polymorphism with pregnancy outcome.
    Huang LL, Tong JR, Huang Y, Wei YN, Chen HF, Chen Y, Su JY, Deng L.
    Eur Rev Med Pharmacol Sci; 2023 Jan 31; 27(1):166-171. PubMed ID: 36647865
    [Abstract] [Full Text] [Related]

  • 25. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M, Zare-Shehneh M, Neamatzadeh H, Abedinzadeh M, Karami H.
    Asian Pac J Cancer Prev; 2015 Jan 31; 16(11):4525-30. PubMed ID: 26107198
    [Abstract] [Full Text] [Related]

  • 26. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
    Guo S, Jiang X, Chen X, Chen L, Li X, Jia Y.
    Gene; 2015 Jul 01; 565(1):90-5. PubMed ID: 25841988
    [Abstract] [Full Text] [Related]

  • 27. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
    Xu R, Wu H, Zhang S, Zhou H, Liang L.
    Neurosci Lett; 2018 Sep 14; 683():69-74. PubMed ID: 29953924
    [Abstract] [Full Text] [Related]

  • 28. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression.
    Rai V.
    Cell Mol Biol (Noisy-le-grand); 2017 Jul 31; 63(6):60-67. PubMed ID: 28968218
    [Abstract] [Full Text] [Related]

  • 29. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
    Lv L, Wang P, Sun B, Chen G.
    Tumour Biol; 2014 Jan 31; 35(1):227-37. PubMed ID: 23897558
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations.
    Rai V.
    Asian Pac J Cancer Prev; 2015 Jan 31; 16(18):8093-100. PubMed ID: 26745044
    [Abstract] [Full Text] [Related]

  • 31. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis.
    Hou X, Chen X, Shi J.
    Gene; 2015 Jul 01; 565(1):39-44. PubMed ID: 25839940
    [Abstract] [Full Text] [Related]

  • 32. Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis.
    Li L, Yu H, Zhang H, Wang J, Hu W.
    Herz; 2022 Dec 01; 47(6):553-563. PubMed ID: 35089369
    [Abstract] [Full Text] [Related]

  • 33. Association between the methylenetetrahydrofolate reductase gene C677T polymorphism and sudden sensorineural hearing loss: a meta-analysis.
    Shu J, Yin S, Tan AZ, He M.
    Eur Arch Otorhinolaryngol; 2015 Sep 01; 272(9):2267-74. PubMed ID: 25012704
    [Abstract] [Full Text] [Related]

  • 34. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.
    Breast Cancer Res Treat; 2010 Sep 01; 123(2):499-506. PubMed ID: 20135343
    [Abstract] [Full Text] [Related]

  • 35. Methylenetetrahydrofolate reductase gene polymorphisms and recurrent pregnancy loss in China: a systematic review and meta-analysis.
    Chen H, Yang X, Lu M.
    Arch Gynecol Obstet; 2016 Feb 01; 293(2):283-90. PubMed ID: 26399758
    [Abstract] [Full Text] [Related]

  • 36. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
    Rai V, Kumar P.
    Neurol Sci; 2018 Dec 01; 39(12):2033-2041. PubMed ID: 30267335
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
    Yu L, Chang K, Han J, Deng S, Chen M.
    PLoS One; 2013 Dec 01; 8(2):e55835. PubMed ID: 23431363
    [Abstract] [Full Text] [Related]

  • 39. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
    Chen PL, Li WT, Wang J, Jiang YD, Wu P, Chen T, Zheng SB.
    Genet Mol Res; 2015 Dec 29; 14(4):19191-202. PubMed ID: 26782572
    [Abstract] [Full Text] [Related]

  • 40. Significant association between MTHFR C677T polymorphism and thyroid cancer risk: evidence from a meta-analysis.
    Chen Y, Wang B, Yan S, Wang YG.
    Genet Test Mol Biomarkers; 2014 Oct 29; 18(10):695-702. PubMed ID: 25007377
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.